Interrupting methotrexate to improve immunity after COVID-19 booster vaccination: is it really worth it?
Lancet Respir Med
.
2022 Sep;10(9):e80.
doi: 10.1016/S2213-2600(22)00271-5.
Authors
Anselm Jorda
1
,
Markus Zeitlinger
2
Affiliations
1
Department of Clinical Pharmacology, Medical University of Vienna, Vienna 1090, Austria.
2
Department of Clinical Pharmacology, Medical University of Vienna, Vienna 1090, Austria. Electronic address: markus.zeitlinger@meduniwien.ac.at.
PMID:
36057280
PMCID:
PMC9428575
DOI:
10.1016/S2213-2600(22)00271-5
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19* / prevention & control
Enzyme-Linked Immunosorbent Assay
Humans
Methotrexate* / therapeutic use
Vaccination
Substances
Methotrexate